See every side of every news story
Published loading...Updated

Exercise may benefit colon cancer patients as much as some drugs: Study

  • A 2025 study led by Dr. Sara Char at Dana-Farber found exercise benefits colon cancer patients comparably to some drugs.
  • This study arose as colorectal cancer rates rise among younger adults, potentially driven by environmental factors beyond genetics.
  • The study showed patients in an exercise program had a 28% lower risk of recurrence and an 80% five-year disease-free survival rate.
  • Pfizer presented data on Braftovi, a targeted drug combo doubling survival to 30 months versus 15 months with standard treatment.
  • These findings indicate lifestyle changes and targeted therapies could enhance treatment, suggesting exercise be an essential treatment component.
Insights by Ground AI
Does this summary seem wrong?

249 Articles

All
Left
40
Center
126
Right
17
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 69% of the sources are Center
69% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Savage Nation broke the news in on Friday, May 30, 2025.
Sources are mostly out of (0)